CTRI/2018/09/015667已完成未知
Anemia profile in cancer patients and its response to erythropoietin stimulating agents (ESAs), substrate supplementation (Iron, Vitamin B12 and Folic acid) and blood transfusion requirements
BLK SuperSpeciality Hospital0 个研究点目标入组 350 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. All the patients above the age of 18 years with primary diagnosis of CRA after hematological evaluation
- •2.ECOG performance status 0-2
- •3. Patient should be willing to consent to be a part of the study afterexplaining the nature of the study.
排除标准
- •1. Patients who were in the immediate post-operative period (3 weeks) and/or critically ill (life expectancy <3 months)
- •2. Patients diagnosed with leukemias
- •3. Patients who were recently transfused with PRBC within a month prior to inclusion
- •4. Contraindication for ESA or iron preparations
- •5.Pregnant or breast-feeding women
研究者
相似试验
尚未招募
3 期
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in ChildrensNeoplasmsChemotherapeutic-Induced AnemiaAnemiaNCT05704894Blau Farmaceutica S.A.320
终止
4 期
Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron DeficiencySolid Cancer Metastatic DiseaseLymphoid DiseaseNCT02213653Centre Francois Baclesse24
已完成
不适用
Retrospective Study on the Incidence and Management of Anemia in OncologyCancerAnemiaNCT04779840Weprom349
Unknown
不适用
Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological MalignancyAcute Myeloid LeukemiaAnemiaNCT02860598Hospices Civils de Lyon104
撤回
2 期
Intravenous Iron in Combination With Standard of Care Immunotherapy in MelanomaAnemia, Iron DeficiencyMelanomaNCT06508827Mateusz Opyrchal5